AARTI DRUGS LTD. (AARTIDRUGS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 661.11 641.54 605.94 619.99 590.51 598.33 556.60 676.76 590.51 652.79 601.71 720.30
YOY Revenue Growth % -4.78% -6.71% -8.74% -16.49% -10.68% -6.74% -8.14% 9.16% 0% 9.1% 8.1% 6.43%
Other Income 0.60 0.68 1.67 1.08 0.31 1.48 11.90 1.87 0.31 0.09 1.23 0.76
Total Income 661.71 642.22 607.61 621.07 590.82 599.81 568.50 678.63 590.82 652.88 602.94 721.06
Total Expenses + 539.30 531.72 531.64 503.72 539.71 482.86 513.27 607.48 539.71 592.47 573.92 650.70
Cost of Materials Consumed 408.61 395.66 401.07 366.64 357.25 345.58 369.79 375.14 357.25 385.06 334.52 427.19
Employee Benefit Expense 25.47 25.45 25.55 25.87 30.80 26.56 27.76 31.35 30.80 33.07 33.16 32.28
Other Expenses 105.22 110.61 105.02 111.21 112.24 110.72 115.72 115.18 112.24 127.15 126.88 141.80
Operating Profit 121.81 109.82 74.30 116.27 50.80 115.47 43.33 69.28 50.80 60.32 27.79 69.60
OPM % 18.4% 17.1% 12.3% 18.8% 8.6% 19.3% 7.8% 10.2% 8.6% 9.2% 4.6% 9.7%
Profit Before Tax + 63.53 56.27 51.55 64.18 51.11 45.88 50.76 71.15 51.11 60.41 29.02 70.36
Tax Expense 15.56 16.67 14.84 16.87 -2.86 10.92 13.67 8.38 -2.86 15.25 -11.53 15.10
Tax % 24.5% 29.6% 28.8% 26.3% -5.6% 23.8% 26.9% 11.8% -5.6% 25.2% -39.7% 21.5%
Profit After Tax 47.97 39.60 36.71 47.31 53.97 34.96 37.09 62.77 53.97 45.16 40.55 55.26
EPS (Basic) 5.18 4.29 3.99 5.15 5.91 3.83 4.06 6.88 5.91 4.95 4.44 6.05

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 2,387.03 2,528.58 2,716.05 2,488.65 2,154.78 1,806.09 1,560.94
YOY Revenue Growth % -5.6% -6.9% 9.14% 15.49% 19.31% 15.71% -
Other Income 16.36 4.03 2.19 11.32 4.53 1.48 6.18
Total Income 2,403.39 2,532.61 2,718.24 2,499.97 2,159.31 1,807.57 1,567.12
Total Expenses + 2,191.62 2,106.37 2,290.91 2,136.72 1,618.16 1,507.23 1,292.51
Cost of Materials Consumed 1,438.30 1,571.98 1,768.97 1,666.36 1,221.52 1,141.92 998.90
Employee Benefit Expense 112.10 102.34 92.02 82.81 80.50 69.36 60.92
Other Expenses 445.77 432.05 429.92 387.55 316.14 295.95 232.69
Operating Profit 195.41 422.21 425.14 351.93 536.62 298.86 268.43
OPM % 8.2% 16.7% 15.7% 14.1% 24.9% 16.5% 17.2%
Profit Before Exceptional 211.77 235.53 224.18 269.96 368.79 180.82 131.02
Exceptional Items 0.00 0.00 0.00 0.00 0.22 4.47 0.00
Profit Before Tax + 211.77 235.53 224.18 269.96 369.01 185.29 131.02
Tax Expense 43.67 63.94 57.82 64.96 88.61 43.89 41.27
Tax % 20.6% 27.1% 25.8% 24.1% 24% 23.7% 31.5%
Profit After Tax 168.10 171.59 166.36 205.00 280.40 141.40 89.75
EPS (Basic) 18.35 18.56 17.97 22.12 30.09 60.57 38.48

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 1,236.32 1,111.64 929.04 0.00 0.00 0.00 0.00
Property, Plant & Equipment 856.25 808.16 675.43 0.00 0.00 0.00 0.00
Capital Work in Progress 330.18 225.23 210.35 0.00 0.00 0.00 0.00
Non-Current Investments 22.41 19.97 18.80 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 7.15 1.18 0.79 0.00 0.00 0.00 0.00
Current Assets + 1,338.36 1,320.72 1,492.36 0.00 0.00 0.00 0.00
Inventories 472.93 485.89 516.29 0.00 0.00 0.00 0.00
Trade Receivables 751.18 704.55 864.84 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 4.58 6.74 8.96 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 91.27 91.94 92.60 0.00 0.00 0.00 0.00
Other Equity 1,277.73 1,189.61 1,099.83 0.00 0.00 0.00 0.00
Non-Current Liabilities 368.37 354.86 295.76 0.00 0.00 0.00 0.00
Current Liabilities 836.97 795.54 932.98 0.00 0.00 0.00 0.00
Total Liabilities 1,205.34 1,150.40 1,228.74 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 244.58 358.92 134.20 69.64 0.00 0.00 0.00
Cash from Investing Activities -164.63 -223.65 -163.97 -148.86 0.00 0.00 0.00
Cash from Financing Activities -82.12 -136.03 16.54 92.02 0.00 0.00 0.00
Net Increase/Decrease in Cash -2.17 -0.76 -13.23 12.80 0.00 0.00 0.00